Synapses are tiny cell protrusions where electrochemical impulses pass between nerves. Prolonged stress in the brain causes synapse withdrawal and maladaptive changes to circuits that are linked to the development of major depressive disorder.

Postdoctoral Researcher Patrik Hollós and colleagues used a light-activated optogenetic tool to switch off the activity of a protein called JNK specifically in synapses.

– Using a light beam to inhibit the JNK protein prevented synapses from shrinking in response to stress. Specifically the internalisation of a receptor called “AMPAR”, an early event in synapse disassembly, was blocked, explains Hollós.

JNK Is a Stress Sensor in Synapses and May Elicit the Effects of Ketamine

Researchers also found that the novel, fast-acting anti-depressant ketamine inhibited the JNK protein while preventing synapse retraction.

– These results show that the JNK protein is a stress sensor in synapses. When activated, it triggers the disassembly of synapse machinery followed by rapid synapse regression. Conversely, inhibiting the JNK protein makes synapses able to withstand chronic endocrine stress. This may be relevant for conditions where hormonal stress leads to synapse elimination but also to control synapse number under normal homeostatic conditions, says team leader Eleanor Coffey.

These findings help us to understand how stress dismantles synapses, and provides clues for novel targeted therapies.

The study was published as a research highlight in the open access journal of the Society for Neuroscience, eNeuro.

Research was conducted at Turku Bioscience Centre a joint research facility of the University of Turku andÅbo Akademi University.



Blocking activation of the JNK protein in synapses stops synapses from retracting. Temporal colour coding shows that when the JNK protein is inhibited in synapses using a light beam, a structural protein called “actin” freezes in time. Changing the cells cytoskeleton is part of an array of molecular events that JNK triggers to destabilize synapses.

For more information contact Research Director Eleanor Coffey, Turku Bioscience, eleanor.coffey@bioscience.fi